A rumour broke this morning that Gildan (GIL) is circling Hanesbrands (HBI) in what would be an opportunistic $5B bid - representing a mid-9s EV/EBITDA multiple, passing the quick and dirty accretion check.

While straying from its focus on organic growth, there’s an obvious strategic rationale for the deal. GIL should be able to drive margin expansion at HBI, and could unlock additional growth from its existing retail distribution.

The timing works too, as an offer would come at a point where HBI has to turned inwards, sacrificing growth and selling off assets to reduce its debt load as it manages through tariff impacts.

The catch? Financing. Gildan’s currently within its leverage target range and with cash on hand, would have roughly $400M to spend before breaching the top end. Either leverage is going higher, or Gildan will issue equity… or both.

You might be interested in…

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.